首站-论文投稿智能助手
典型文献
The mechanism behind activation of the Nod-like receptor family protein 3 inflammasome in Parkinson's disease
文献摘要:
Previous studies have shown that the ATP-P2X4 receptor signaling pathway mediates the activation of the Nod-like receptor family protein3 (NLRP3) inflammasome. The NLRP3 inflammasome may promote renal interstitial inflammation in diabetic nephropathy. As inflammation also plays an important role in the pathogenesis of Parkinson's disease, we hypothesized that the ATP-P2X4 receptor signaling pathway may activate the NLRP3 inflammasome in Parkinson's disease. A male rat model of Parkinson's disease was induced by stereotactic injection of 6-hydroxydopamine into the pars compacta of the substantia nigra. The P2X4 receptor and the NLRP3 inflammasome (interleukin-1β and interleukin-18) were activated. Intracerebroventricular injection of the selective P2X4 receptor antagonist 5-(3-bromophenyl)-1,3-dihydro-2H-benzofuro[3,2-e]-1,4-diazepin-2-one (5-BDBD) or knockdown of P2X4 receptor expression by siRNA inhibited the activation of the NLRP3 inflammasome and alleviated dopaminergic neurodegeneration and neuroinflammation. Our results suggest that the ATP-P2X4 receptor signaling pathway mediates NLRP3 inflammasome activation, dopaminergic neurodegeneration, and dopamine levels. These findings reveal a novel role of the ATP-P2X4 axis in the molecular mechanisms underlying Parkinson's disease, thus providing a new target for treatment. This study was approved by the Animal Ethics Committee of Qingdao University, China, on March 5, 2015 (approval No. QYFYWZLL 26119).
文献关键词:
作者姓名:
Jing Wang
作者机构:
Department of Neurology,the Affiliated Hospital of Qingdao University,Qingdao,Shandong Province,China;Brain Science Center,Academy of Military Medical Sciences of PLA,Beijing,China
引用格式:
[1]Jing Wang-.The mechanism behind activation of the Nod-like receptor family protein 3 inflammasome in Parkinson's disease)[J].中国神经再生研究(英文版),2022(04):898-904
A类:
Intracerebroventricular,bromophenyl,benzofuro,diazepin,BDBD,QYFYWZLL
B类:
behind,activation,Nod,like,receptor,family,inflammasome,Parkinson,disease,Previous,studies,have,shown,that,ATP,P2X4,signaling,pathway,mediates,protein3,NLRP3,may,promote,renal,interstitial,diabetic,nephropathy,also,plays,important,role,pathogenesis,hypothesized,male,model,was,induced,by,stereotactic,injection,hydroxydopamine,into,pars,compacta,substantia,nigra,interleukin,were,activated,selective,antagonist,dihydro,2H,one,knockdown,expression,siRNA,inhibited,alleviated,dopaminergic,neurodegeneration,neuroinflammation,Our,results,suggest,levels,These,findings,reveal,novel,axis,molecular,mechanisms,underlying,thus,providing,new,target,treatment,This,study,approved,Animal,Ethics,Committee,Qingdao,University,China,March,approval
AB值:
0.487748
相似文献
Effect of electroacupuncture on inflammatory signal expression in local tissues of rats with chronic pelvic pain syndrome based on purinergic 2X7 receptor/NOD-like receptor pyrin domain-containing 3 signal pathway
XU Chang;LI Na;WU Xiaoling;DAI Xingye;YANG Zhiwen;SUN Qianhui;SHI Tianyu;CHAI Yemao;PANG Dandan;CHENG Kai-Major in Acupuncture and Tuina,school of Acupuncture and Tuina,Beijing University of Chinese Medicine,Beijing 100029,China;Experimental science of acupuncture and moxibustion teaching and research section,school of Acupuncture and Tuina,Beijing University of Chinese Medicine,Beijing 100029,China;Complex laboratory,school of Acupuncture and Tuina,Beijing University of Chinese Medicine,Beijing 100029,China;Academy of Chinese Medical Sciences,Beijing 100700,China;Meridians and acupoints teaching and research section,school of Acupuncture and Tuina,Beijing University of Chinese Medicine,Beijing 100029,China
GPR84 signaling promotes intestinal mucosal inflammation via enhancing NLRP3 inflammasome activation in macrophages
Qing Zhang;Lin-hai Chen;Hui Yang;You-chen Fang;Si-wei Wang;Min Wang;Qian-ting Yuan;Wei Wu;Yang-ming Zhang;Zhan-ju Liu;Fa-jun Nan;Xin Xie-State Key Laboratory of Drug Research,The National Center for Drug Screening,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;School of Pharmaceutical Science and Technology,Hangzhou Institute for Advanced Study,University of Chinese Academy of Sciences,Hangzhou 310024,China;University of Chinese Academy of Sciences,Beijing 100049,China;Department of Gastroenterology,The Shanghai Tenth People's Hospital,Tongji University,Shanghai 200072,China;Burgeon Therapeutics Co.,Ltd,Shanghai 201203,China;Yantai Key Laboratory of Nanomedicine and Advanced Preparations,Yantai Institute of Materia Medica,Yantai 264000,China
Therapeutic potential of colchicine in cardiovascular medicine:a pharmacological review
Fan-shun Zhang;Qing-ze He;Chengxue Helena Qin;Peter J.Little;Jian-ping Weng;Suo-wen Xu-Institute of Endocrine and Metabolic Diseases,The First Affiliated Hospital of USTC,Division of Life Science and Medicine,University of Science and Technology of China,Hefei 230001,China;Faculty of Pharmacy and Pharmaceutical Sciences,Monash Institute of Pharmaceutical Sciences,Monash University(Parkville Campus),381 Royal Parade,Parkville 3052 VIC,Australia;Sunshine Coast Health Institute,University of the Sunshine Coast,Birtinya 4575 QLD,Australia;School of Pharmacy,The University of Queensland,Woolloongabba 4102 QLD,Australia;Biomedical Sciences and Health Laboratory of Anhui Province,University of Science&Technology of China,Hefei 230027,China
IMM-H007 attenuates isoprenaline-induced cardiac fibrosis through targeting TGFβ1 signaling pathway
Shuai-xing Wang;Ye-nan Feng;Shan Feng;Ji-min Wu;Mi Zhang;Wen-li Xu;You-yi Zhang;Hai-bo Zhu;Han Xiao;Er-dan Dong-Department of Cardiology and Institute of Vascular Medicine,Peking University Third Hospital,NHC Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides,Key Laboratory of Molecular Cardiovascular Science,Ministry of Education,Beijing Key Laboratory of Cardiovascular Receptors Research,Beijing 100191,China;State Key Laboratory for Bioactive Substances and Functions of Natural Medicines,Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study,Institute of Materia Medica,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100050,China
Intrarenal 1-methoxypyrene,an aryl hydrocarbon receptor agonist,mediates progressive tubulointerstitial fibrosis in mice
Gang Cao;Hua Miao;Yan-ni Wang;Dan-qian Chen;Xia-qing Wu;Lin Chen;Yan Guo;Liang Zou;Nosratola D.Vaziri;Ping Li;Ying-yong Zhao-School of Pharmacy,Zhejiang Chinese Medical University,No.548 Binwen Road,Hangzhou 310053,China;Faculty of Life Science&Medicine,Northwest University,No.229 Taibai North Road,Xi'an 710069,China;Beijing Key Lab for Immune-Mediated Inflammatory Diseases,Institute of Clinical Medical Science,Department of Nephrology,China-Japan Friendship Hospital,No.2 Yinghua East Road,Beijing 100029,China;Department of Internal Medicine,University of New Mexico,1700 Lomas Blvd NE,Albuquerque,NM 87131,USA;School of Food and Bioengineering,Chengdu University,No.2025 Chengluo Avenue,Chengdu 610106,China;Division of Nephrology and Hypertension,School of Medicine,University of California Irvine,1001 Health Sciences Rd,Irvine,CA 92897,USA
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。